ALLARITY THERAPEUTICS, INC. — Income Charts
2 years of history · ending 2021-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$-1M
Gross Profit
—
R&D
$14M
D&A
$106K
Operating Income
$-27M
EBITDA
$-26M
Interest Expense
$99K
Interest Income
—
Other Income/Expense
—
Pretax Income
—
Tax Provision
$133K
Net Income
$-27M
Operating Margin
1971.5%
Net Margin
1978.3%
Effective Tax Rate
—
Deferred Tax Assets
$81K
Deferred Tax Liabilities
$2M
DTA Valuation Allowance
$4M
NOL Carryforwards
$9M
ETR (Continuing Operations)
22.0%
ETR Federal Statutory
—
Operating Lease Cost
$134K
Income YoY Variation
-219.2%